Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR)

NCT04594915 is registered in ClinicalTrials.gov with Daiichi Sankyo Turkey, a Daiichi Sankyo Company as lead sponsor.

NCT NCT04594915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04594915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR)
Lead sponsor
Daiichi Sankyo Turkey, a Daiichi Sankyo Company
Phase
Observational
Overall status
Completed
Start date
August 14, 2020
Completion date
June 21, 2023
Enrollment
1,053 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation